Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof-of-concept Trial to Evaluate Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children

NCT03893097 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT03893097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03893097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof-of-concept Trial to Evaluate Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Phase 3
Overall status
Completed
Start date
October 14, 2019
Completion date
March 4, 2021
Enrollment
726 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schistosoma haematobium, schistosoma mansoni